Sohu Pharmaceutical | Kori Wei'an: Biomedical products occupy 21 seats in the top 100 new brands in the world

Produced | Sohu Health

Author | Zhou Yichuan

Edit | Yuan Yue

The FierePharma website reports that the new crown vaccine and digital health innovation are the focus of the current social society. On the recent list of global new brands released by Kori Wei'an, 21 seats related to biopharmaceuticals are related to the new crown virus.

The report is based on more than 20 million new applications for trademarks around the world and selects 100 new brands that have entered the public vision in the past two years. They will become an influential brand in the industry.

Pfizer/Bynetak's new crown vaccine, COMIRNATY, Astrikon's Vaxzevria has become a well -known product in a short time in a short time, and NOVAXOVID is also among the list. It has been approved in Europe and has just received FDA recently. Authorized.

In addition to the new crown, Roche's home -based blood glucose self -test SmartGuide, the artificial AI product Calantic of Bayer Medical Imaging, BimzelX, which is better than psoriasis drugs, is also among the top 100.

In the interview, the relevant person in charge introduced that the list of the new brand showed the investment level of the brand and the market size they wanted to cover. For example, the new crown vaccine is a high -level brand investment project, and trademark applications have been made in a large number of countries and regions in a short time.

In the past, although brand investment in the pharmaceutical industry was huge, products were often only related to a small number of people. The current situation has undergone tremendous changes. The global popularity of the epidemic has allowed the public to strengthen attention to the pharmaceutical industry, especially the vaccine field. In the next few years, New Crown Treatment Drugs will become the next wave of high -profile products, such as PhaxLovid of Pfizer, Molnupiravir in Meroshadong, and so on.

- END -